273 related articles for article (PubMed ID: 15635725)
21. 5'-aminocarbonyl phosphonates as new zidovudine depot forms: antiviral properties, intracellular transformations, and pharmacokinetic parameters.
Khandazhinskaya AL; Yanvarev DV; Jasko MV; Shipitsin AV; Khalizev VA; Shram SI; Skoblov YS; Shirokova EA; Kukhanova MK
Drug Metab Dispos; 2009 Mar; 37(3):494-501. PubMed ID: 19106116
[TBL] [Abstract][Full Text] [Related]
22. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL
J Pharm Pharm Sci; 1998; 1(3):108-14. PubMed ID: 10948398
[TBL] [Abstract][Full Text] [Related]
23. AZT-5'-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agent.
Jan ST; Zhu Z; Tai HL; Shih MJ; Venkatachalam TK; Uckun FM
Antivir Chem Chemother; 1999 Jan; 10(1):47-52. PubMed ID: 10079879
[TBL] [Abstract][Full Text] [Related]
24. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
[TBL] [Abstract][Full Text] [Related]
25. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.
Walker DM; Malarkey DE; Seilkop SK; Ruecker FA; Funk KA; Wolfe MJ; Treanor CP; Foley JF; Hahn FF; Hardisty JF; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):283-98. PubMed ID: 17358026
[TBL] [Abstract][Full Text] [Related]
26. In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.
Mengoni F; Lichtner M; Battinelli L; Marzi M; Mastroianni CM; Vullo V; Mazzanti G
Planta Med; 2002 Feb; 68(2):111-4. PubMed ID: 11859458
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
[TBL] [Abstract][Full Text] [Related]
28. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
Sriram D; Srichakravarthy N; Bal TR; Yogeeswari P
Biomed Pharmacother; 2005 Sep; 59(8):452-5. PubMed ID: 16154314
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.
Rossi L; Franchetti P; Pierigé F; Cappellacci L; Serafini S; Balestra E; Perno CF; Grifantini M; Caliò R; Magnani M
J Antimicrob Chemother; 2007 Apr; 59(4):666-75. PubMed ID: 17327293
[TBL] [Abstract][Full Text] [Related]
31. Tuftsin: its chemistry, biology, and clinical potential.
Fridkin M; Najjar VA
Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
[TBL] [Abstract][Full Text] [Related]
32. [The anti-HIV activity of glycyrrhizic acid penta-O-nicotinate].
Pliasunova OA; Il'ina TV; Kiseleva IaIu; Fediuk NV; Baltina LA; Tolstikov GA; Pokrovskiĭ AG
Vestn Ross Akad Med Nauk; 2004; (11):42-6. PubMed ID: 15651664
[TBL] [Abstract][Full Text] [Related]
33. 3'-azido-3'-deoxythymidine induces deletions in L5178Y mouse lymphoma cells.
Wang J; Chen T; Honma M; Chen L; Moore MM
Environ Mol Mutagen; 2007; 48(3-4):248-57. PubMed ID: 17358034
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
[TBL] [Abstract][Full Text] [Related]
35. Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms.
Dagan S; Tzehoval E; Fridkin M; Feldman M
J Biol Response Mod; 1987 Dec; 6(6):625-36. PubMed ID: 3502474
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of 3'-azido-3'-deoxythymidine (AZT) on normal human polymorphonuclear cell and monocyte-macrophage functional capacities.
De Simone C; Maffione AB; Calvello R; Nacci C; Sciannameo G; Greco B; Caradonna L; Pece S; Antonaci S; Jirillo E
Immunopharmacol Immunotoxicol; 1996 May; 18(2):161-78. PubMed ID: 8771365
[TBL] [Abstract][Full Text] [Related]
37. Dapsone and HIV-1 replication in primary cultures of lymphocytes and monocyte-derived macrophages.
Duval X; Clayette P; Dereuddre-Bosquet N; Fretier P; Martin M; Salmon-Ceron D; Gras G; Vilde JL; Dormont D
AIDS; 1997 Jun; 11(7):943-4. PubMed ID: 9189230
[No Abstract] [Full Text] [Related]
38. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells.
Hoever G; Groeschel B; Chandra P; Doerr HW; Cinatl J
Int J Mol Med; 2003 Jun; 11(6):743-7. PubMed ID: 12736716
[TBL] [Abstract][Full Text] [Related]
39. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.
Masquelier B; Neau D; Boucher S; Lavignolle-Aurillac V; Schrive MH; Recordon-Pinson P; Ragnaud JM; Fleury H
Antivir Ther; 2006; 11(6):827-30. PubMed ID: 17310827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
